Korologou-Linden Roxanna, Leyden Genevieve M, Relton Caroline L, Richmond Rebecca C, Richardson Tom G
MRC Integrative Epidemiology Unit at the University of Bristol, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK.
Hum Mol Genet. 2021 Jan 22;32(6):885-96. doi: 10.1093/hmg/ddab016.
Integrating findings from genome-wide association studies with molecular datasets can develop insight into the underlying functional mechanisms responsible for trait-associated genetic variants. We have applied the principles of Mendelian randomization (MR) to investigate whether brain-derived gene expression (n = 1194) may be responsible for mediating the effect of genetic variants on eight cognitive and psychological outcomes (attention deficit hyperactivity disorder (ADHD), Alzheimer's disease, bipolar disorder, depression, intelligence, insomnia, neuroticism and schizophrenia). Transcriptome-wide analyses identified 83 genes associated with at least one outcome (PBonferroni < 6.72 × 10-6), with multiple-trait colocalization also implicating changes to brain-derived DNA methylation at nine of these loci. Comparing effects between outcomes identified evidence of enrichment which may reflect putative causal relationships, such as an inverse relationship between genetic liability towards schizophrenia risk and cognitive ability in later life. Repeating these analyses in whole blood (n = 31 684), we replicated 58.2% of brain-derived effects (based on P < 0.05). Finally, we undertook phenome-wide evaluations at associated loci to investigate pleiotropic effects with 700 complex traits. This highlighted pleiotropic loci such as FURIN (initially implicated in schizophrenia risk (P = 1.05 × 10-7)) which had evidence of an effect on 28 other outcomes, as well as genes which may have a more specific role in disease pathogenesis (e.g. SLC12A5 which only provided evidence of an effect on depression (P = 7.13 × 10-10)). Our results support the utility of whole blood as a valuable proxy for informing initial target identification but also suggest that gene discovery in a tissue-specific manner may be more informative. Finally, non-pleiotropic loci highlighted by our study may be of use for therapeutic translational endeavours.
将全基因组关联研究的结果与分子数据集相结合,有助于深入了解与性状相关的遗传变异背后的潜在功能机制。我们应用孟德尔随机化(MR)原理,研究脑源性基因表达(n = 1194)是否可能介导遗传变异对八种认知和心理结果(注意力缺陷多动障碍(ADHD)、阿尔茨海默病、双相情感障碍、抑郁症、智力、失眠、神经质和精神分裂症)的影响。全转录组分析确定了83个与至少一种结果相关的基因(PBonferroni < 6.72×10-6),多性状共定位也表明其中九个位点的脑源性DNA甲基化发生了变化。比较不同结果之间的效应,发现了富集证据,这可能反映了假定的因果关系,例如精神分裂症风险的遗传易感性与晚年认知能力之间的负相关关系。在全血样本(n = 31684)中重复这些分析,我们复制了58.2%的脑源性效应(基于P < 0.05)。最后,我们在相关位点进行了全表型评估,以研究与700种复杂性状的多效性效应。这突出了多效性位点,如弗林蛋白酶(FURIN)(最初与精神分裂症风险相关(P = 1.05×10-7)),有证据表明它对其他28种结果有影响,以及可能在疾病发病机制中起更特定作用的基因(例如SLC12A5,仅提供了对抑郁症有影响的证据(P = 7.13×10-10))。我们的结果支持全血作为一种有价值的替代物用于初步靶点识别的实用性,但也表明以组织特异性方式进行基因发现可能更具信息性。最后,我们研究中突出的非多效性位点可能有助于治疗转化研究。